C-peptide binding to human cell membranes:: Importance of Glu27

被引:52
作者
Pramanik, A
Ekberg, K
Zhong, Z
Shafqat, J
Henriksson, M
Jansson, O
Tibell, A
Tally, M
Wahren, J
Jörnvall, H
Rigler, R
Johnansson, J [1 ]
机构
[1] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden
[2] Karolinska Inst, Dept Surg Sci, SE-17177 Stockholm, Sweden
[3] Karolinska Inst, Dept Mol Med, SE-17177 Stockholm, Sweden
[4] Huddinge Hosp, Dept Transplantat Surg, SE-14186 Huddinge, Sweden
关键词
C-peptide binding; fluorescence correlation spectroscopy; Ala-scan analysis; C-peptide pentapeptide fragment; glutamate receptor;
D O I
10.1006/bbrc.2001.4917
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In addition to its established role in proinsulin folding, C-peptide has a function in regulation of cellular activity. The 31-residue peptide influences renal, vascular, and metabolic functions in patients with insulin-dependent diabetes mellitus. Binding to cells has been demonstrated for C-peptide, which can be displaced by its C-terminal pentapeptide. We have now used fluorescence correlation spectroscopy to investigate structural requirements on the pentapeptide part for C-peptide binding. All pentapeptide residues, E(27)GSLQ(31), were individually replaced with Ala and the capacity of the resulting peptides to displace rhodamine-labelled full-length human C-peptide from human renal tubular cell membranes was determined. This showed that Glu27 is essential for displacement, while replacement of Gly28 with Ala has little effect, and replacement of any of the three most C-terminal residues had intermediate effects. Moreover, free Glu displaces full-length C-peptide to about 50%, while free Ala, C-peptide(1-26), and the truncated pentapeptide, corresponding to the tetrapeptide G(28)SLG(31), have no displacing capacity. The peptides EVARQ (corresponding to the rat C-terminal pentapeptide) and ELGGGPGAG (corresponding to positions 11-19 of human C-peptide) do not displace human C-peptide. These results indicate that Glu27 of C-peptide is critically involved in binding to cellular targets, a zool Academic Press.
引用
收藏
页码:94 / 98
页数:5
相关论文
共 26 条
[1]   GONADOTROPIN-RELEASING-HORMONE INHIBITORY AUTOFEEDBACK BY SUBPRODUCTS ANTAGONIST AT N-METHYL-D-ASPARTATE RECEPTORS - A MODEL OF AUTOCRINE REGULATION OF PEPTIDE SECRETION [J].
BOURGUIGNON, JP ;
GONZALEZ, MLA ;
GEARD, A ;
FRANCHIMONT, P .
ENDOCRINOLOGY, 1994, 134 (03) :1589-1592
[2]   Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus [J].
Forst, T ;
Kunt, T ;
Pohlmann, T ;
Goitom, K ;
Engelbach, M ;
Beyer, J ;
Pfützner, A .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (10) :2036-2041
[3]   Unordered structure of proinsulin C-peptide in aqueous solution and in the presence of lipid vesicles [J].
Henriksson, M ;
Shafqat, J ;
Liepinsh, E ;
Tally, M ;
Wahren, J ;
Jörnvall, H ;
Johansson, J .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (02) :337-342
[4]   Specific binding of proinsulin C-peptide to intact and to detergent-solubilized human skin fibroblasts [J].
Henriksson, M ;
Pramanik, A ;
Shafqat, J ;
Zhong, ZH ;
Tally, M ;
Ekberg, K ;
Wahren, J ;
Rigler, R ;
Johansson, J ;
Jornvall, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 280 (02) :423-427
[5]   Prevention of vascular and neural dysfunction in diabetic rats by C-peptide [J].
Ido, Y ;
Vindigni, A ;
Chang, K ;
Stramm, L ;
Chance, R ;
Heath, WF ;
DiMarchi, RD ;
DiCera, E ;
Williamson, JR .
SCIENCE, 1997, 277 (5325) :563-566
[6]   Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus [J].
Johansson, BL ;
Borg, K ;
Fernqvist-Forbes, E ;
Kernell, A ;
Odergren, T ;
Wahren, J .
DIABETIC MEDICINE, 2000, 17 (03) :181-189
[7]   EFFECTS OF C-PEPTIDE ON BLOOD-FLOW, CAPILLARY DIFFUSION CAPACITY AND GLUCOSE-UTILIZATION IN THE EXERCISING FOREARM OF TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS [J].
JOHANSSON, BL ;
LINDE, B ;
WAHREN, J .
DIABETOLOGIA, 1992, 35 (12) :1151-1158
[8]   THE INFLUENCE OF HUMAN C-PEPTIDE ON RENAL-FUNCTION AND GLUCOSE-UTILIZATION IN TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS [J].
JOHANSSON, BL ;
SJOBERG, S ;
WAHREN, J .
DIABETOLOGIA, 1992, 35 (02) :121-128
[9]  
Johansson BL, 1996, DIABETOLOGIA, V39, P687
[10]  
JOHANSSON BL, 1993, J CLIN ENDOCR METAB, V77, P976, DOI 10.1210/jc.77.4.976